Seed VC · Belgium

Newton Biocapital

Active

What they invest in

Support projects for promising solutions in chronic health conditions, with a focus on alleviating patient and societal burdens. The firm participates proactively as board members, supporting portfolio companies with preclinical and clinical program selection across a range of technologies and disease areas.

Who they back

DeepTechHealthtechBiotechChronic DiseasesSeedSeries ASeries B+

Business models

biotech_therapeutics, deeptech_ip

Customer segments

Researchers, Patients

Geography

Europe, APAC

Recent investments

  • AdipoPharma
  • Cellaïon
  • Prism BioLab

+ 3 more deals. Score your deck to see the full investment history.

The people who write checks

12 partners on file at Newton Biocapital, with the firm's email pattern for cold outreach. Score your deck (free, 30 seconds) to unlock direct contact for this firm and 47,000+ others.

We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.

Why this firm matters for fundraising founders

Newton Biocapital writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Newton Biocapital alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.

At a glance

Based in
Belgium
Last known deal
Feb 2022
Portfolio last checked
Oct 6, 2026
Website
newtonbiocapital.com ↗

Other firms investing in DeepTech

See all investors

Is Newton Biocapital the right fit for your deck?

Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Newton Biocapital is one of them, and we'll tell you exactly where they sit in your top 100.